Feasibility and Safety of Perilla Seed Oil as an Additional Antioxidative Therapy in Patients with Mild to Moderate Dementia

Table 4

Comparison between Alzheimer and non-Alzheimer subtypes in enrolled and drop-out groups.

Volunteers according to the type of dementia enrolled ()	Alzheimer’s disease	Non-Alzheimer’s disease	value
Perilla seed oil	49 (52.17%)	45 (47.87%)	0.173
Placebo	37 (42.04%)	5 (58%)
Volunteers according to the type of dementia drop-out ( )
Perilla seed oil	15 (55.5%)	12 (44.4%)	0.24
Placebo	12 (40%)	18 (60%)